ViviGen Cellular Bone Matrix

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
70	広範脊柱管狭窄症	1

70. 広範脊柱管狭窄症

臨床試験数 : 95 / 薬物数 : 169 - (DrugBank : 61) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 90

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04007094 (ClinicalTrials.gov)	February 12, 2019	24/4/2019	Single-Armed Use of ViviGen Cellular Bone Matrixin Patients Undergoing Posterolateral Lumbar Surgery ...	A Prospective, Single Arm Study of Patients Undergoing Posterolateral Lumbar Fusion (Without Interbo ...	Degenerative Disc Disease;Spinal Stenosis;Spondylosis;Spondylolisthesis	Drug: ViviGen Cellular Bone Matrix	Ohio State University	DePuy Synthes	Recruiting	18 Years	N/A	All	50	Phase 4	United States

First Previous1Next Last